The nation of Zimbabwe has turned down a substantial US healthcare agreement valued at 367 million US dollars (£272m) over five years due to the United States' demand for confidential data.
This rejection came to light following a internal memorandum from December was disclosed, indicating that President Emmerson Mnangagwa deemed the deal was "skewed".
A government spokesman later explained that the US was requesting health data for research and profit but refused to share the benefits from future medical innovations.
"We must now begin the difficult and regrettable process of scaling back our health assistance in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy indicated the United States had provided more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has appealed for further negotiations to find a deal acceptable to all parties so the nation's critical HIV treatment initiative can continue.
Broader Implications
This development comes after a similar case in Kenya, where a high court suspended a related health funding agreement after legal challenges were filed about the security of citizens' medical information.
After returning to office last year, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).
The agency had managed assistance for the US government, but Trump argued its expenditure was "wasteful" and his government was seeking government-to-government deals to boost transparency and accountability.
Based on reports, 16 African countries have so far signed similar health pacts, constituting over $18.3bn in committed funds.
Details of the Declined Deal
The money for Zimbabwe was intended to gone towards "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this collaboration could have provided significant benefits for the people of Zimbabwe, particularly the 1.2 million currently receiving antiretroviral therapy via US-supported programmes," the Ambassador said.
However, official spokesman Nick Mangwana maintained the arrangement was "unfair".
"The proposal required Zimbabwe to provide its biological resources and data for a long time, with no equivalent assurance of benefiting from any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that provided information," his statement read.
"In essence, our country would provide the raw materials for medical research with no certainty that the final treatments would be available to our people should a future pandemic emerge."
Sovereignty and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were upending frameworks already established via the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system designed to deal with potential global health emergencies.
"This system is designed to guarantee that when a nation contributes its information, the resulting advantages – such as medicines and cures – are shared equitably, not commercialised exclusively by those with the capability to develop them."
These objections regarding the US deal "must not be interpreted as anti-American sentiment," he added.
"We welcome continued dialogue with our US partners on how subsequent co-operation could be arranged in a manner that honours the sovereignty and interests of each country."
Health Experts Response
A leading public health body said it recognised the government's concerns, but urged that talks should continue given that much of the country's Aids initiatives relied on foreign aid.
"In cases where technical issues arise, such as those relating to data governance or agreement terms, these can often be addressed through technical clarification and negotiated safeguards," it commented.
The situation highlights the ongoing challenges between accepting much-needed international aid and safeguarding a country's data in an increasingly interconnected world.